Cardiology

Advances in cholesterol-lowering drugs within five years

(Medical Xpress)—A leading cardiology expert at the University of Adelaide predicts that a new class of advanced cholesterol-reducing drugs could be ready for patient use within the next five years, helping to prevent heart ...

Medications

Merck recalls cholesterol drug Liptruzet (Update)

(HealthDay)—Packaging defects have prompted a recall of a combination cholesterol drug called Liptruzet, produced by Merck & Co., temporarily affecting the entire U.S. stock.

Health

Being underweight increases death risk of CAD women by two-fold

Being underweight increases the death risk of women with coronary artery disease (CAD) by 2-fold, according to research presented at the ESC Congress today by Dr Aziza Azimi from Denmark. The study suggests that underweight ...

page 9 from 22